Page 69 - Retail Pharmacy Magazine October 2020

Osteoarthritis pain A joint solution to stay active For everyday Panadol Osteo Voltaren Osteo Gel 12 Hourly for flare-up days • Topical diclofenac concentrates at site of application,3 to relieve pain and reduce inflammation for up to 12 hours4 • Low systemic absorption for a lower risk of side effects than oral NSAIDs5 – only 3–7% of the applied dose is absorbed into the blood6 • For use up to 3 weeks consecutively4 osteoarthritis pain... • Modified release paracetamol with clinically-studied efficacy of up to 8 hours1,2 • Bi-layer formulation provides immediate and sustained release of paracetamol1 • 3x daily dosing – convenient dosing with the potential to enhance compliance and therefore pain relief1 Please consult the prescribing information for Panadol Osteo before recommendation. For further information, please contact GlaxoSmithKline Consumer Healthcare (FREECALL 1800 028 533). Panadol Osteo contains Paracetamol 665 mg per caplet. Indications and dosage: For temporary relief of persistent pain of osteoarthritis. Adults and children ≥ 12 years: 2 caplets every 6–8 hours. Voltaren Osteo Gel 12 Hourly contains diclofenac diethylamine 23.2 mg/g. Indication: For short-term (up to 3 weeks) pain relief of mild and localised forms of osteoarthritis of the knees and fingers. References: 1. Panadol Osteo (paracetamol). Australian approved Product Information. Ermington: GSK Consumer Healthcare. Approved 13 December 2016. 2. Bacon TH. Aust Pain Soc 2001:63–64. 3. Brune K. Curr Res Opin 2007;23:2985–95. 4. Voltaren Osteo Gel 12 Hourly. Patient Information Leaflet. 5. Derry S, Conaghan PG, Da Silva J et al. Cochrane Database Syst Rev 2016; Iss 4: Art no. CD007400. 6. Davies NM, Anderson KE. Clin Pharmacokinet 1997;33;184–213. Trade marks are owned by or licensed to the GSK group of companies. ©2020 GSK group of companies or its licensor. All rights reserved. GlaxoSmithKline Consumer Healthcare, 82 Hughes Avenue, Ermington NSW 2115. GLCOCH1545. 09/20. PM-AU-PAN-20-00095.